To include your compound in the COVID-19 Resource Center, submit it here.

Interleukin-1 (IL-1): Began Phase I Trial

Regeneron Pharmaceuticals Inc. (REGN), Tarrytown, N.Y.

Read the full 61 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE